{"id":1173598,"date":"2026-09-07T21:48:34","date_gmt":"2026-09-07T21:48:34","guid":{"rendered":"https:\/\/www.europesays.com\/fr\/1173598\/"},"modified":"2026-09-07T21:48:34","modified_gmt":"2026-09-07T21:48:34","slug":"dans-le-grand-sud-la-healthtech-resiste-et-attire-les-capitaux","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/fr\/1173598\/","title":{"rendered":"Dans le Grand Sud, la healthtech r\u00e9siste et attire les capitaux"},"content":{"rendered":"<p>Face \u00e0 l\u2019attentisme persistant des march\u00e9s, la fili\u00e8re sant\u00e9 des r\u00e9gions Paca et Occitanie d\u00e9montre sa solidit\u00e9. Au premier semestre\u00a02026, les adh\u00e9rents du p\u00f4le de comp\u00e9titivit\u00e9 <a href=\"https:\/\/www.laprovence.com\/article\/economie\/2897859365172414\/technologies-de-la-sante-le-grand-sud-resiste-avec-309-millions-d-euros-leves\" target=\"_self\" rel=\"nofollow noopener\">Eurobiomed<\/a> ont mobilis\u00e9 228,8\u00a0millions d\u2019euros de financements priv\u00e9s, en hausse de 20% sur un an, auxquels s\u2019ajoutent 18,8\u00a0millions d\u2019euros d\u2019aides publiques.<\/p>\n<p>\u00ab\u00a0Nous sommes sur une ann\u00e9e tendanciellement meilleure que la pr\u00e9c\u00e9dente\u00a0\u00bb, constate<a href=\"https:\/\/www.laprovence.com\/article\/economie\/5205539789235914\/ne-pas-croire-que-l-ia-va-remplacer-le-medecin-lanalyse-demilie-royere-directrice-generale-deurobiomed\" target=\"_self\" rel=\"nofollow noopener\"> \u00c9milie Roy\u00e8re, directrice g\u00e9n\u00e9rale d\u2019Eurobiomed<\/a>. Au-del\u00e0 des montants, la dirigeante salue la tenue de la fili\u00e8re\u00a0: \u00ab\u00a0Eurobiomed continue de jouer un r\u00f4le d\u2019association refuge. Le taux de d\u00e9faillances reste contenu autour de 7%, un niveau tr\u00e8s raisonnable au regard de la forte proportion de tr\u00e8s petites structures dans notre r\u00e9seau.\u00a0\u00bb<\/p>\n<p>Cinq champions captent la mise, l\u2019amor\u00e7age sous tension<\/p>\n<p><a href=\"https:\/\/www.laprovence.com\/article\/economie\/446519516368315\/la-biotech-marseillaise-vect-horus-fait-entrer-les-medicaments-dans-le-cerveau\" target=\"_self\" rel=\"nofollow noopener\">Ces performances masquent toutefois une concentration marqu\u00e9e<\/a>. Plus de la moiti\u00e9 des fonds priv\u00e9s lev\u00e9s ce semestre est capt\u00e9e par cinq locomotives r\u00e9gionales\u00a0: Sensorion, MedinCell, Abionyx, Median et S\u00eameia. Une tendance compl\u00e9t\u00e9e par des op\u00e9rations d\u2019envergure, comme le partenariat strat\u00e9gique de 75\u00a0millions d\u2019euros nou\u00e9 entre Innate Pharma et le su\u00e9dois Sobi, ou le refinancement de la&#8230;<\/p>\n","protected":false},"excerpt":{"rendered":"Face \u00e0 l\u2019attentisme persistant des march\u00e9s, la fili\u00e8re sant\u00e9 des r\u00e9gions Paca et Occitanie d\u00e9montre sa solidit\u00e9. Au&hellip;\n","protected":false},"author":2,"featured_media":1173599,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[2814],"tags":[5734,1111,11,4185,1446,110458,33,1777,674,1011,27,2515,151,884,12,882,25,69884,7053],"class_list":["post-1173598","post","type-post","status-publish","format-standard","has-post-thumbnail","category-marseille","tag-5734","tag-actu","tag-actualites","tag-attire","tag-dans","tag-e-sante","tag-economie","tag-eu","tag-europe","tag-fr","tag-france","tag-grand","tag-les","tag-marseille","tag-news","tag-provence-alpes-cote-dazur","tag-republique-francaise","tag-resiste","tag-sud"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@fr\/117231963837795174","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/1173598","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/comments?post=1173598"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/1173598\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media\/1173599"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media?parent=1173598"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/categories?post=1173598"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/tags?post=1173598"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}